GCM
GMAB icon

Graham Capital Management’s Genmab GMAB Stock Holding History

Graham Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$559K Buy
+20,343
New +$541K 0.01% 674
2025
Q4 		– Sell
-14,167
Closed -$435K – 1366
2025
Q3 		$435K Buy
+14,167
New +$345K 0.01% 671
2025
Q2 		– Sell
-71,452
Closed -$1.4M – 1401
2025
Q1 		$1.4M Buy
71,452
+16,035
+29% +$336K 0.02% 450
2024
Q4 		$1.16M Buy
55,417
+15,321
+38% +$337K 0.02% 449
2024
Q3 		$978K Buy
40,096
+16,405
+69% +$439K 0.02% 474
2024
Q2 		$595K Buy
+23,691
New +$672K 0.01% 531
2024
Q1 		– Sell
-11,944
Closed -$380K – 1153
2023
Q4 		$380K Buy
+11,944
New +$375K 0.01% 665

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Graham Capital Management's GMAB Position: Q2 2026 in Review

Graham Capital Management opened a new position in Genmab (GMAB) in Q2 2026: 20,343 shares worth $559K. The stake represents 0.01% of the portfolio and ranks #674 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in GMAB as recently as Q3 2025.

Graham Capital Management first reported a position in GMAB in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.4M in Q1 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Graham Capital Management held 20,343 shares of Genmab worth $559K as of Q2 2026.
  • Genmab was a new Graham Capital Management position in Q2 2026.
  • Genmab made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #674 holding.
  • Graham Capital Management first reported a position in Genmab in Q4 2023 and has held it in 7 quarters since.
  • Graham Capital Management's Genmab position peaked at $1.4M in Q1 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.